- £578.54m
- £651.22m
- £277.33m
- 94
- 32
- 54
- 66
Annual income statement for GB, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 199 | 218 | 242 | 279 | 277 |
| Cost of Revenue | |||||
| Gross Profit | 144 | 153 | 172 | 198 | 195 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 176 | 182 | 219 | 391 | 319 |
| Operating Profit | 22.8 | 35.5 | 23.4 | -112 | -41.4 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 20.6 | 34.3 | 21.7 | -119 | -50.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 17.1 | 26.9 | 15.3 | -120 | -48.6 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 17.1 | 26.9 | 15.3 | -120 | -48.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 17.1 | 26.9 | 15.3 | -120 | -48.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.1 | 0.129 | 0.096 | 0.033 | 0.048 |
| Dividends per Share |